Nexus Pharmaceuticals Inc
Nexus Pharmaceuticals Inc appears in FDA public data with 1 recall, 0 510(k) clearances, 8 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-925-2013, Class II) was initiated on August 1, 2013.
Summary
- Total Recalls
- 1
- 510(k) Clearances
- 0
- Inspections
- 8
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-925-2013 | Class II | Benztropine Mesylate Injection, USP, 2 mg/mL(1 mg/1 mL), 2 mL Single Dose Vial, Rx only, Manufacture | August 1, 2013 |